Ignite Creation Date:
2024-05-06 @ 6:57 PM
Last Modification Date:
2024-10-26 @ 2:58 PM
Study NCT ID:
NCT05846516
Status:
RECRUITING
Last Update Posted:
2024-07-08
First Post:
2023-04-18
Brief Title:
A Study to Evaluate ATP150ATP152 VSV-GP154 and Ezabenlimab in Patients With KRAS G12DG12V Mutated PDAC KISIMA-02
Sponsor:
Amal Therapeutics
Organization:
Amal Therapeutics
Organization Data
Organization:
Amal Therapeutics
Class:
INDUSTRY
Study ID:
KISIMA-02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Amal Therapeutics
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Boehringer Ingelheim | INDUSTRY |